Muneer Satter, Director, Ten Percent Owner at Immunic, holds 7.41M shares in Annexon Biosciences (Ticker: ANNX), holds 16.61M shares in Aileron Therapeutics (Ticker: ALRN), holds 5.62M shares in Aadi Bioscience (Ticker: AADI). Most recently, Muneer Satter Bought ― shares of Annexon Biosciences on Dec 28, 2023 for an estimated value of 1.01M.
Muneer Satter latest transaction was an Informative Buy of $1.01M.
What was Muneer Satter's most profitable transaction?
Muneer Satter’s most profitable transaction was an Informative Buy of IMUX stock on April 23, 2014. The return on the trade was 138.20%.
What is Muneer Satter's role in Immunic?
Muneer Satter's role in Immunic is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.